Guardant Health, Inc.
GH
$46.17
$1.984.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.90M | -95.16M | -111.01M | -107.75M | -102.63M |
| Total Depreciation and Amortization | 10.04M | 10.24M | 10.45M | 10.60M | 10.62M |
| Total Amortization of Deferred Charges | -- | -- | 646.00K | 645.00K | -- |
| Total Other Non-Cash Items | 49.81M | 45.57M | 38.23M | 57.65M | 51.70M |
| Change in Net Operating Assets | -20.24M | -23.34M | -2.83M | -12.20M | -53.70M |
| Cash from Operations | -60.29M | -62.69M | -64.51M | -51.06M | -94.00M |
| Capital Expenditure | -5.65M | -4.46M | -18.88M | -4.20M | -5.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00M | 307.32M | 29.41M | -290.63M | 0.00 |
| Cash from Investing | -10.65M | 302.86M | 10.53M | -294.83M | -5.08M |
| Total Debt Issued | -5.03M | 5.03M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.24M | 768.00K | 5.03M | 20.00K | 9.58M |
| Repurchase of Common Stock | -7.42M | -60.51M | -8.02M | -2.87M | -3.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.84M | -12.14M | 59.00K | -31.00K | -438.00K |
| Cash from Financing | 1.62M | -66.85M | -2.94M | -2.89M | 5.90M |
| Foreign Exchange rate Adjustments | 937.00K | 773.00K | -1.70M | 1.90M | -837.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.37M | 174.10M | -58.61M | -346.87M | -94.02M |